Ivermectin is one of the most talked-about—and misunderstood—drugs of the past several years.
But when you step away from the headlines and look at the science, a much more interesting story emerges.
This isn’t about politics. It’s about biology.
Prefer to listen without the ads? Become a Ben Bikman Insider.
A Proven Drug with a Global Impact
Ivermectin was discovered in the 1970s and later earned the Nobel Prize in Physiology or Medicine for its role in treating parasitic diseases like river blindness.
For decades, it has been used safely by hundreds of millions of people worldwide, and it remains on the World Health Organization’s list of essential medicines.
This is not a fringe drug—it’s one with a long, well-established history in human medicine.
A New Look at Metabolism
While ivermectin is best known for treating parasites, newer research suggests it may also affect how our cells produce and use energy.
At the center of this is the mitochondria—the tiny power plants inside our cells.
Studies show ivermectin can influence a key part of the mitochondrial energy system. When this happens, the body activates a sensor called AMPK, which helps cells respond to low energy.
AMPK plays an important role in metabolic health. When activated, it can:
- Reduce inflammation
- Improve energy balance
- Slow abnormal cell growth
Why This Matters
These effects connect ivermectin to several important areas of metabolic health.
Some preclinical studies suggest it may:
- Influence inflammation through key signaling pathways
- Support better blood sugar control
- Improve insulin sensitivity
There is also growing interest in how ivermectin affects cancer cell metabolism, where disrupting energy production may slow growth and trigger cell death.
It’s important to note that most of this research is still preclinical—meaning it comes from lab and animal studies, not large human trials.
Where the Science Stands
Early findings are promising, but more research is needed.
Still, ivermectin presents something compelling:
a drug with a strong safety record, clear biological mechanisms, and emerging evidence that it may influence key metabolic pathways.
That combination alone makes it worth studying further.
Final Thoughts
But it may be a reminder that sometimes the most interesting discoveries come from looking deeper at drugs we thought we already understood.
From mitochondria to inflammation to insulin signaling, ivermectin touches many of the systems that drive metabolic health.
And that’s why it continues to be an area of growing scientific interest.